Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD

Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD

Abstract Few studies have directly compared the incidence of pneumonia in patients on common chronic obstructive pulmonary disease (COPD) treatments such as long-acting muscarinic antagonists (LAMA) with those on inhaled corticosteroids and long-acting β2-agonist (ICS/LABA). Moreover, risk factors f...

Full description

Bibliographic Details
Main Authors: Eung Gu Lee, Youlim Kim, Yong Il Hwang, Kwang Ha Yoo, So Eun Lee, Kyung Yoon Jung, Doik Lee, Yong Bum Park, Chin Kook Rhee
Format: Article
Language:English
Published: Nature Portfolio 2023-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-35223-3

Similar Items

Similar Items